Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 16;20(4):3471.
doi: 10.3390/ijerph20043471.

The Role of Preoperative Chronic Statin Therapy in Heart Transplant Receipts-A Retrospective Single-Center Cohort Study

Dragos-Florin Baba  1   2 , Horatiu Suciu  1   3 , Calin Avram  4 , Alina Danilesco  2 , Diana Andreea Moldovan  1 , Radu Catalin Rauta  5 , Laurentiu Huma  1   2 , Ileana Anca Sin  2
Affiliations

The Role of Preoperative Chronic Statin Therapy in Heart Transplant Receipts-A Retrospective Single-Center Cohort Study

Dragos-Florin Baba et al. Int J Environ Res Public Health. .

Abstract

Background: Statin therapy has been proven to reduce the risk of cardiovascular events. The objective of our retrospective study was to investigate the relationship between preoperative chronic administration of statins to postoperative 2-month heart transplantation complications.

Methods: A total number of 38 heart transplantation recipients from the Cardiovascular and Transplant Emergency Institute of Târgu Mureș between May 2014 and January 2021 were included in our study.

Results: In logistic regression, we found a statistical significance between statin treatment and the presence of postoperative complications of any cause (OR: 0.06, 95% CI: 0.008-0.56; p = 0.0128), simultaneously presenting an elevated risk for early-postoperative acute kidney injury (AKI). From the statin group, atorvastatin therapy had a higher risk of type 2 diabetes mellitus (T2DM) development (OR: 29.73, 95% CI: 1.19-741.76; p = 0.0387) and AKI (OR: 29.73, 95% CI: 1.19-741.76; p = 0.0387). C-reactive protein (CRP), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-c) represented risk factors, atorvastatin administration being independently associated with lower CRP values.

Conclusions: Chronic previous administration of statins represented a protective factor to the development of 2-month postoperative complications of any cause in heart transplant receipts.

Keywords: C-reactive protein; atorvastatin; complications; heart transplant; statin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure A1
Figure A1
A schematic illustration of the associations between drug therapy and 2-month presence of postoperative complications of any cause.
Figure 1
Figure 1
Inclusion criteria and study design.
Figure 2
Figure 2
Prognostic values of CRP, TC, and LDL-c in the prediction of a 2-month complication of any cause after heart transplant.
See this image and copyright information in PMC

References

    1. Brink J.G., Hassoulas J. The first human heart transplant and further advances in cardiac transplantation at Groote Schuur Hospital and the University of Cape Town—With reference to: The operation. A human cardiac transplant: An interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. Cardiovasc. J. Afr. 2009;20:31–35. - PMC - PubMed
    1. Metra M., Ponikowski P., Dickstein K., McMurray J.J., Gavazzi A., Bergh C.-H., Fraser A.G., Jaarsma T., Pitsis A., Mohacsi P., et al. Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2007;9:684–694. doi: 10.1016/j.ejheart.2007.04.003. - DOI - PubMed
    1. DeFilippis E.M., Khush K.K., Farr M.A., Fiedler A., Kilic A., Givertz M.M. Evolving Characteristics of Heart Transplantation Donors and Recipients. J. Am. Coll. Cardiol. 2022;79:1108–1123. doi: 10.1016/j.jacc.2021.11.064. - DOI - PubMed
    1. McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M., Burri H., Butler J., Čelutkienė J., Chioncel O., et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2021;42:3599–3726. doi: 10.1093/eurheartj/ehab368. - DOI - PubMed
    1. Kosiborod M.N., Jhund P.S., Docherty K., Diez M., Petrie M.C., Verma S., Nicolau J., Merkely B., Kitakaze M., DeMets D.L., et al. Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction. Circulation. 2020;141:90–99. doi: 10.1161/CIRCULATIONAHA.119.044138. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances